Adverse effects of the humanized antibodies used as cancer therapeutics-Reference-Cited by-同舟云学术

Adverse effects of the humanized antibodies used as cancer therapeutics

Published:2006-07 Issue:4 Volume:18 Page:316-320
ISSN:1040-8746
Container-title:Current Opinion in Oncology
language:en
Short-container-title:

Author:

Klastersky Jean

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference24 articles.

1. Development of humanized antibodies as cancer therapeutics.;Zhengxing Qu, Griffiths;Methods,2005

2. Alemtuzumab for B-cell chronic lymphocytic leukaemia;Tahar;Issues Emerg Health Technol,2005

3. Hepatitis B virus reactivation and alemtuzumab therapy;Iannitto;Eur J Haematol,2005

4. Alemtuzumab in the treatment of chronic lymphocytic leukaemia;Robak;BioDrugs,2005

5. Low-dose intravenous alemtuzumab therapy in pretreated patients affected by chronic lymphocytic leukemia: a single center experience;Laurenti;Haematologica,2005

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional polysaccharide-coated SPIONs for in vitro mRNA delivery in breast cancer cells;Materials Advances;2024

2. Overcoming the On‐Target Toxicity in Antibody‐Mediated Therapies via an Indirect Active Targeting Strategy;Advanced Science;2023-01-22

3. The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis;PLOS ONE;2022-12-01

4. Safety Profile of Monoclonal Antibody Compared With Traditional Anticancer Drugs: An Analysis of Henan Province Spontaneous Reporting System Database;Frontiers in Pharmacology;2022-01-25

5. Autoimmune-mediated hemotoxicities;Current Opinion in Toxicology;2020-02